These are the company's first financial statements prepared under FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland, including Section 1A Small Entities. The financial statements for the year ended 31 December 2024 were prepared under FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The date of transition to FRS 102 is 1 January 2024.
The comparative figures for the year ended 31 December 2024 have been restated. The accounting policies set out in note 2 have been applied in preparing the opening balance sheet at 1 January 2024, the comparative figures and the current year figures.
The following adjustments were made on transition:
(a) Development costs: Under FRS 105, development expenditure was written off as incurred. Qualifying development expenditure has been reinstated as an intangible fixed asset, less the amortisation that would have been charged had the policy always applied. This gives a net book value of £683,298 at 1 January 2024 and £1,148,875 at 31 December 2024. In the year ended 31 December 2024, development expenditure of £705,450 was capitalised. It had previously been charged to staff costs (£634,183) and other charges (£71,267). An amortisation charge of £239,873 has been recognised.
(b) Share-based payments: FRS 105 does not require equity-settled share-based payments to be recognised. Under FRS 102 Section 26, the fair value of options granted to the company's employees under the parent company's EMI scheme is charged to profit or loss over the vesting period, with a corresponding credit to equity as a capital contribution from the parent. A charge of £47,971 has been recognised in the year ended 31 December 2024. This adjustment has no effect on total equity.
(c) Deferred tax: The capitalised development costs give rise to a deferred tax liability. This is fully offset by a deferred tax asset on unused tax losses, recognised in accordance with the policy in note 2.8. Accordingly, no net deferred tax adjustment arises on transition.
Reconciliation of equity:
As at 1 January 2024
Equity as previously reported under FRS 105 (£1,131,930)
Development costs, net of amortisation (a) £683,298
Equity as restated under FRS 102 (£448,632)
As at 31 December 2024
Equity as previously reported under FRS 105 £562,243
Development costs, net of amortisation (a) £1,148,875